Amit Anand, MD

Mass General Brigham, Harvard Medical School, Boston, Massachusetts

  • 4Articles
  • 7KReads
  • 2000–2025Active
  • 25Collaborators
  • 2Citations

About

Amit Anand, MD, is affiliated with Mass General Brigham and Harvard Medical School in Boston, Massachusetts. Anand has published extensively on major depressive disorder, bipolar disorder, and electroconvulsive therapy, focusing on treatment-resistant depression and pharmacologic augmentation strategies. Notable topics include the cognitive effects of ketamine and electroconvulsive therapy, zonisamide treatment for bipolar depression, and norepinephrine dysfunction in depression. Anand’s work has appeared in Psychiatrist.com publications from 2000 to 2025.

Publications

JCP
Comparing the Cognitive Effects of Repeated IV Ketamine and ECT in Patients with Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial
Original Research

Comparing the Cognitive Effects of Repeated IV Ketamine and ECT in Patients with Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D Trial

September 3, 2025

Patients treated with ketamine demonstrated superior cognitive functioning compared with those treated with ECT following a 3-week treatment course. No differences between treatments were observed among responders in at...
, , , et al
JCP
Original Research

A Preliminary Open-Label Study of Zonisamide Treatment for Bipolar Depression in 10 Patients

February 15, 2005

, , , et al
JCP
Original Research

Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Double-Blind, Randomized, Controlled Trial

February 1, 2004

, , , et al
JCP
Article

Norepinephrine Dysfunction in Depression

August 30, 2000

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe